DDX58 Antikörper (AA 203-925) (APC)
Kurzübersicht für DDX58 Antikörper (AA 203-925) (APC) (ABIN7984281)
Target
Alle DDX58 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 203-925
-
Verwendungszweck
- Anti-DDX58/RIG-1 Antibody APC Conjugated
-
Kreuzreaktivität (Details)
- No cross reactivity with other proteins.
-
Homologie
- Human RIGI shares 78.2% amino acid (aa) sequence identity with mouse RIGI.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human DDX58/RIG-1 recombinant protein (Position: K203-K925). Human RIGI shares 78.2% amino acid (aa) sequence identity with mouse RIGI.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Haltbarkeit
- 12 months
-
-
- DDX58 (DEAD (Asp-Glu-Ala-Asp) Box Polypeptide 58 (DDX58))
-
Andere Bezeichnung
- RIGI
-
Hintergrund
-
Background: DEAD box proteins, characterized by the conserved motif Asp-Glu-Ala-Asp (DEAD), are putative RNA helicases which are implicated in a number of cellular processes involving RNA binding and alteration of RNA secondary structure. This gene encodes a protein containing RNA helicase-DEAD box protein motifs and a caspase recruitment domain (CARD). It is involved in viral double-stranded (ds) RNA recognition and the regulation of the antiviral innate immune response. Mutations in this gene are associated with Singleton-Merten syndrome 2.
Gene Full Name: RNA sensor RIG-I
-
Gen-ID
- 23586
-
UniProt
- O95786
-
Pathways
- Activation of Innate immune Response, Hepatitis C
Target
-